Skip to main content
. 2022 Mar 29;2022(3):CD012867. doi: 10.1002/14651858.CD012867.pub3

Ng 2020.

Methods Study design: prospective cohort study
Setting/Country: single center/Hong Kong
Participants Inclusion criteria: American Society of Anesthesiology Class 3/4; obstructive uropathy or refractory urinary retention with prostate size > 50 mL
Interventions Group A: prostatic arterial embolization
Group B: transurethral resection of prostate
Outcomes Primary outcome
  • Successful rate of voiding trial within 4 weeks after treatment.


Secondary outcomes
  • Length of hospitalization

  • Change in prostate size

  • Change in serum prostate‐specific antigen

  • Functional measures

  • Complications

Notes Abstract only